![]() |
市場調查報告書
商品編碼
2049152
眼科雷射市場報告:按產品、適應症、最終用戶和地區分類(2026-2034 年)Ophthalmic Lasers Market Report by Product, Indication, End-User, and Region 2026-2034 |
||||||
2025年全球眼科雷射市場規模達14億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到20億美元,2026年至2034年的複合年成長率為4.10%。市場成長的主要促進因素包括:對微創手術需求的不斷成長、飛秒雷射在白內障手術中的應用日益廣泛以及眼科疾病發病率的上升。
眼科疾病盛行率增加
視力相關疾病病例的不斷增加是推動市場成長的主要因素。例如,根據世界衛生組織2021年的報告,全球至少有22億人患有視力障礙,包括近視或遠視。世衛組織也指出,視力障礙加劇了全球因未矯正近視(2,440億美元)和老花眼(254億美元)造成的經濟負擔。世界經濟論壇2022年1月發布的新聞稿顯示,近視盛行率顯著上升。據預測,到2050年,全球一半人口將患有近視。此外,根據世界衛生組織2021年10月發布的新聞稿,約有8,840萬人因屈光未得到治療而失明。另外,全球老年人口的成長(老年人更容易患眼科疾病)也進一步推動了對眼科雷射的需求。例如,目前美國約有6,200萬65歲及以上的老年人,居住人口的18%。預計到2054年,65歲及以上的老年人口將達到8,400萬,約佔總人口的23%。
技術進步
雷射技術的不斷進步,尤其是在精度、速度和安全性等方面的提升,正推動眼科雷射在各種眼科疾病治療中的應用。此外,飛秒雷射技術在諸如LASIK雷射手術、白內障手術和角膜移植等精準微創手術中的應用日益廣泛,為整個市場創造了巨大的成長潛力。因此,各大市場參與者紛紛推出配備先進技術的眼科雷射設備,以提升診斷、治療方案製定和個人化照護水準。例如,2022年4月,Nova Eye Medical在歐洲和亞太地區推出了其新一代套管重建裝置「iTrack Advance」。 iTrack Advance的關鍵特性在於其採用了先前iTrack裝置中使用的獨特的照明光纖尖端,使外科醫生能夠持續監測裝置在施萊姆氏管內的位置。同樣在同月,Lumibird集團推出了其「Capsulo Nd:YAG雷射」。該設備被設計成一個完全整合、多功能的雷射平台,能夠有效率且精準地進行水晶體囊切開術和虹膜切開術。因此,預計這些努力將在未來幾年內推動眼科雷射市場的收入成長。
將產品應用範圍擴展到傳統視力矯正之外。
眼科雷射應用範圍的拓展,使其不再局限於傳統的視力矯正,而是擴展到治療糖尿病視網膜病變、老齡化黃斑部病變(AMD)和視網膜靜脈阻塞等視網膜疾病,這也推動了全球眼科雷射市場的成長。在糖尿病視網膜病變的治療中,雷射光凝固術常用於阻斷滲漏的血管或破壞可能導致視力喪失的異常血管。此外,糖尿病視網膜病變病例的不斷增加也提升了眼科雷射的市場佔有率。例如,根據IMARC的數據,2023年全球糖尿病視網膜病變市場規模達81億美元。展望未來,IMARC Group預測,2024年至2032年間,該市場將以5.2%的複合年成長率成長,到2032年市場規模將達到130億美元。同樣,眼科雷射在老齡化黃斑部病變(AMD)中靶向並阻斷異常血管、降低視力進一步喪失風險方面的應用日益廣泛,也推動了市場成長。例如,根據2020年8月發表在《英國眼科雜誌》上的一篇研究論文,黃斑部病變(AMD)是歐洲視力障礙和失明的主要原因。歐洲約有6700萬人患有老齡化黃斑部病變(AMD)。根據對眼科雷射市場的預測,視網膜疾病患者數量的成長與市場成長呈正相關。
The global ophthalmic lasers market size reached USD 1.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4.10% during 2026-2034. Increasing demand for minimally invasive procedures, growing adoption of femtosecond lasers for cataract surgery, and rising prevalence of ophthalmic disorders are some of the key factors driving the market growth.
Increasing Prevalence of Eye Disorders
The increasing cases of vision-related disorders are primarily driving the growth of the market. For instance, according to the WHO 2021, at least 2.2 billion people had near or distant vision impairment across the globe. WHO also stated that vision impairment poses a global financial burden associated with vision impairment from uncorrected myopia (US$ 244 Billion) and presbyopia (US$ 25.4 billion). In January 2022, a press release by the World Economic Forum indicated that rates of short-sightedness (myopia) rose significantly. By 2050, it's even predicted that half of the world's population will be short-sighted. Moreover, according to the October 2021 press release by the World Health Organization, approximately 88.4 million people suffered blindness due to unaddressed refractive errors. Besides this, the rising geriatric population across the globe, who are more prone to developing eye disorders, is further catalyzing the ophthalmic lasers market demand. For instance, there are currently roughly 62 million adults aged 65 and older living in the U.S., accounting for 18% of the population. By 2054, 84 million adults aged 65 and older will make up an estimated 23% of the population.
Technological Advancements
Ongoing advancements in laser technology, particularly in areas such as precision, speed, and safety, are driving the adoption of ophthalmic lasers for various eye conditions. Moreover, the increasing adoption of femtosecond laser technology for precise and minimally invasive procedures such as LASIK, cataract surgery, and corneal transplantation is offering lucrative growth opportunities to the overall market. In line with this, various key market players are launching ophthalmic lasers with advanced technologies for enhanced diagnostics, treatment planning, and personalized patient care. For instance, in April 2022, Nova Eye Medical launched its next-generation canaloplasty device, iTrack Advance, in Europe and Asia-Pacific. The iTrack Advance features include a proprietary illuminated fiber optic tip of the original iTrack device to allow the surgeon to continuously monitor the location of the device in Schlemm's canal. Similarly, in the same month and year, Lumibird Group launched the Capsulo Nd: YAG laser. The device is designed to be a fully integrated, versatile laser platform, enabling efficient and accurate capsulotomy and iridotomy treatments. Thus, such initiatives are expected to propel the ophthalmic lasers market revenue in the coming years.
Expanding Product Application Beyond Traditional Vision Correction
The diversification of ophthalmic laser applications beyond traditional vision correction, including treatment of retinal disorder, such as diabetic retinopathy, age-related macular degeneration (AMD), and retinal vein occlusion, is also catalyzing the growth of the global ophthalmic lasers market. In diabetic retinopathy, laser photocoagulation is commonly used to seal leaking blood vessels or to destroy abnormal blood vessels that may be causing vision loss. Moreover, the rising cases of diabetic retinopathy are propelling the ophthalmic lasers market share. For instance, according to IMARC, the global diabetic retinopathy market size reached US$ 8.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032. Similarly, the escalating utilization of ophthalmic lasers in AMD to target and seal abnormal blood vessels, reducing the risk of further vision deterioration, is also contributing to the market growth. For instance, according to a research article published in the British Journal of Ophthalmology in August 2020, in Europe, age-related macular degeneration (AMD) is the main cause of visual impairment and blindness. About 67 million people in Europe are affected by age-related macular degeneration (AMD). As per the ophthalmic lasers market forecast, the increasing number of individuals with retinal disorders is directly proportional to market growth.
Femtosecond lasers account for the majority of the global market share
The ophthalmic lasers market report has provided a detailed breakup and analysis of the market based on the product. This includes diode lasers, femtosecond lasers, excimer lasers, Nd: YAG lasers, SLT lasers, and others. According to the report, femtosecond lasers account for the majority of the global market share.
Femtosecond lasers are ultrafast laser systems that emit pulses lasting femtoseconds (10^-15 seconds). They find extensive use in various fields, such as ophthalmology for LASIK surgery, where they precisely reshape corneal tissue, leading to improved vision correction outcomes. Furthermore, femtosecond lasers are pivotal in scientific research, facilitating studies on ultrafast phenomena, such as molecular dynamics and quantum interactions. Their unique properties, including high peak power and ultrashort pulses, make them indispensable tools across diverse applications, promising advancements in medicine, technology, and fundamental science.
Refractive error corrections currently exhibit a clear dominance in the market
Ophthalmic lasers play a crucial role in correcting refractive errors, such as myopia, hyperopia, and astigmatism. In procedures like LASIK (Laser-Assisted In Situ Keratomileusis) and PRK (Photorefractive Keratectomy), these lasers reshape the cornea to adjust its focusing power, thereby improving the vision. An article published in the Journal of Annals of Medicine and Surgery in December 2021 indicated that refractive errors are the most common vision problem and prove to be a significant health issue. Similarly, according to the October 2021 press release by the World Health Organization, approximately 88.4 million people suffer blindness due to unaddressed refractive errors. Such rising cases of refractive errors are anticipated to propel the ophthalmic lasers market's recent price in the coming years.
Hospitals hold the largest market share
Hospitals serve as a crucial hub for the adoption and utilization of these advanced technologies. Moreover, hospitals invest in state-of-the-art ophthalmic laser systems to offer cutting-edge treatments for various eye conditions such as cataracts, glaucoma, and refractive errors. Additionally, hospitals provide a platform for ophthalmologists and eye surgeons to perform surgeries and procedures involving ophthalmic lasers, ensuring access to comprehensive eye care for patients. The presence of these advanced technologies in hospitals contributed to improved patient outcomes, enhanced surgical precision, and expanded treatment options in the field of ophthalmology.
North America currently dominates the global market
The rise in the adoption of highly advanced techniques and systems in the manufacturing of ophthalmic lasers and the technological advancements made in ophthalmic lasers are primarily bolstering the growth of the market in the North American region. Moreover, the rising cases of eye disorders in the region are offering lucrative growth opportunities to the market. For instance, a press release published in February 2022 by the Centers for Disease Control and Prevention (CDC) offered prevalence estimates for the most common eye disorders and eye diseases. Nearly 12 million adults in the United States who were 40 years and above of age had vision impairment, with about a million of them being blind. Besides this, the concerned regulatory authorities are also expediting the approval process for laser technologies, which is further creating a positive outlook for the market. For instance, in December 2021, LASEROPTEK Co., Ltd. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PicoLO Premium picosecond pulse Nd: YAG laser. The approvals of such innovative products in the United States are positively impacting the ophthalmic lasers market outlook.